Jacobs Levy Equity Management Inc. Buys New Position in Trupanion, Inc. (NASDAQ:TRUP)

Jacobs Levy Equity Management Inc. bought a new stake in Trupanion, Inc. (NASDAQ:TRUP) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 14,258 shares of the financial services provider’s stock, valued at approximately $687,000.

Several other institutional investors have also recently added to or reduced their stakes in the company. Gotham Asset Management LLC acquired a new position in Trupanion in the 4th quarter valued at about $234,000. Graham Capital Management L.P. acquired a new position in shares of Trupanion during the 4th quarter valued at about $355,000. Eschler Asset Management LLP acquired a new position in shares of Trupanion during the 4th quarter valued at about $214,000. Deutsche Bank AG increased its stake in shares of Trupanion by 119.4% during the 4th quarter. Deutsche Bank AG now owns 134,546 shares of the financial services provider’s stock valued at $6,485,000 after acquiring an additional 73,227 shares during the last quarter. Finally, Balyasny Asset Management L.P. increased its stake in shares of Trupanion by 368.2% during the 4th quarter. Balyasny Asset Management L.P. now owns 841,254 shares of the financial services provider’s stock valued at $40,548,000 after acquiring an additional 661,559 shares during the last quarter.

Trupanion Trading Up 2.9%

NASDAQ TRUP opened at $46.77 on Friday. Trupanion, Inc. has a one year low of $25.90 and a one year high of $57.90. The company’s 50 day moving average price is $37.96 and its 200 day moving average price is $44.27. The company has a debt-to-equity ratio of 0.39, a quick ratio of 1.66 and a current ratio of 1.71. The firm has a market capitalization of $2.00 billion, a price-to-earnings ratio of -203.35, a PEG ratio of 6.02 and a beta of 1.72.

Trupanion (NASDAQ:TRUP) last posted its quarterly earnings results on Thursday, May 1st. The financial services provider reported ($0.03) EPS for the quarter, beating the consensus estimate of ($0.05) by $0.02. Trupanion had a negative net margin of 0.75% and a negative return on equity of 3.08%. The firm had revenue of $341.98 million for the quarter, compared to analyst estimates of $337.81 million. During the same quarter last year, the firm posted ($0.16) earnings per share. Trupanion’s revenue for the quarter was up 11.7% compared to the same quarter last year. On average, sell-side analysts predict that Trupanion, Inc. will post 0.13 EPS for the current year.

Insider Activity at Trupanion

In other Trupanion news, CEO Margaret Tooth sold 4,000 shares of the stock in a transaction that occurred on Monday, April 21st. The shares were sold at an average price of $33.34, for a total value of $133,360.00. Following the completion of the sale, the chief executive officer now owns 118,784 shares of the company’s stock, valued at $3,960,258.56. This trade represents a 3.26% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, SVP Emily Dreyer sold 14,025 shares of the stock in a transaction that occurred on Friday, March 7th. The shares were sold at an average price of $32.41, for a total transaction of $454,550.25. Following the completion of the sale, the senior vice president now directly owns 27,645 shares of the company’s stock, valued at $895,974.45. This trade represents a 33.66% decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 33,792 shares of company stock worth $1,122,802. Company insiders own 5.42% of the company’s stock.

Analysts Set New Price Targets

A number of research analysts have recently commented on the stock. Piper Sandler dropped their price objective on shares of Trupanion from $57.00 to $52.00 and set an “overweight” rating for the company in a research note on Thursday, February 20th. Lake Street Capital dropped their price objective on shares of Trupanion from $65.00 to $60.00 and set a “buy” rating for the company in a research note on Friday, May 2nd. Finally, Stifel Nicolaus dropped their price objective on shares of Trupanion from $44.00 to $41.00 and set a “hold” rating for the company in a research note on Thursday, February 20th. Two equities research analysts have rated the stock with a hold rating, four have issued a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, Trupanion presently has a consensus rating of “Moderate Buy” and an average target price of $51.80.

Trupanion Profile

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.